External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study
2018 ◽
Vol 36
(12)
◽
pp. 1973-1980
◽
Keyword(s):